Decatur, GEORGIA4 Active Studies

Pulmonary Embolism Clinical Trials in Decatur, GEORGIA

Find 4 actively recruiting pulmonary embolism clinical trials in Decatur, GEORGIA. Connect with local research sites and explore new treatment options.

4
Active Trials
2
Sponsors
1,950
Enrolling

Recruiting Pulmonary Embolism Studies in Decatur

RecruitingDecatur, GEORGIANCT06914895

A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight

The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last about 49 week...

905 participants
Eli Lilly and Company
View Study Details
RecruitingDecatur, GEORGIANCT06972472

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes

The main purpose of this study is to see how orforglipron, compared with placebo, helps improve glycemic control in participants with obesity or with overweight and type 2 diabetes. This trial is part...

600 participants
Eli Lilly and Company
View Study Details
RecruitingDecatur, GEORGIANCT06297603

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes and renal impairment, with inadequate glycemic control on ...

320 participants
Eli Lilly and Company
View Study Details
RecruitingDecatur, GEORGIANCT06897202

A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM

This study is designed to test how well once-weekly MET097 (an ultra-long-acting GLP-1 receptor agonist) works to treat adults with obesity or overweight and type 2 diabetes mellitus (T2DM) compared t...

125 participants
Metsera
View Study Details

About Pulmonary Embolism Clinical Trials in Decatur

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 4 pulmonary embolism clinical trials recruiting participants in Decatur, GEORGIA. These studies are seeking a combined 1,950 participants. Research is being sponsored by Eli Lilly and Company, Metsera. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Decatur — FAQ

Are there pulmonary embolism clinical trials in Decatur?

Yes, there are 4 pulmonary embolism clinical trials currently recruiting in Decatur, GEORGIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Decatur?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Decatur research site will contact you about next steps.

Are clinical trials in Decatur free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Decatur studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 4 active trials in Decatur are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated March 2, 2026 from ClinicalTrials.gov